Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2004
Artificial sweeteners--do they bear a carcinogenic risk?
M R Weihrauch, V Diehl
Aviation, Space, and Environmental Medicine
|
May 20, 1998
Joint NASA-ESA-DARA Study. Part three: cardiorespiratory response to elevated CO2 levels during sleep
A Gundel, J Drescher, M R Weihrauch
Medizinische Klinik (Munich, Germany : 1983)
|
January 5, 2002
[Artificial sweeteners--are they potentially carcinogenic?]
M R Weihrauch, V Diehl, H Bohlen
Aviation, Space, and Environmental Medicine
|
May 20, 1998
Joint NASA-ESA-DARA Study. Part three: characterization of sleep under ambient CO2-levels of 0.7% and 1.2%
A Gundel, R A Parisi, R Strobel, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
October 18, 2001
[Factitious disorders. Hematologic, neurologic and dermatologic symptoms in a physician with factitious disorder]
M R Weihrauch, K Rabe, M Kochanek, et al.
Blood
|
November 8, 2001
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease
M R Weihrauch, D Re, K Scheidhauer, et al.
Nuklearmedizin. Nuclear Medicine
|
February 26, 2003
[Hodgkin's lymphoma in nuclear medicine: diagnostic and therapeutic aspects]
J O Staak, M Dietlein, A Engert, et al.
Clinical and Experimental Immunology
|
December 2, 2008
CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential
E Kondo, L Gryschok, N Klein-Gonzalez, et al.
Annals of Hematology
|
January 25, 2002
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease
M R Weihrauch, D Re, S Bischoff, et al.
British Journal of Cancer
|
October 7, 2010
Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy
V Goede, O Coutelle, J Neuneier, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2004
Artificial sweeteners--do they bear a carcinogenic risk?
M R Weihrauch, V Diehl
Aviation, Space, and Environmental Medicine
|
May 20, 1998
Joint NASA-ESA-DARA Study. Part three: cardiorespiratory response to elevated CO2 levels during sleep
A Gundel, J Drescher, M R Weihrauch
Medizinische Klinik (Munich, Germany : 1983)
|
January 5, 2002
[Artificial sweeteners--are they potentially carcinogenic?]
M R Weihrauch, V Diehl, H Bohlen
Aviation, Space, and Environmental Medicine
|
May 20, 1998
Joint NASA-ESA-DARA Study. Part three: characterization of sleep under ambient CO2-levels of 0.7% and 1.2%
A Gundel, R A Parisi, R Strobel, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
October 18, 2001
[Factitious disorders. Hematologic, neurologic and dermatologic symptoms in a physician with factitious disorder]
M R Weihrauch, K Rabe, M Kochanek, et al.
Blood
|
November 8, 2001
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease
M R Weihrauch, D Re, K Scheidhauer, et al.
Nuklearmedizin. Nuclear Medicine
|
February 26, 2003
[Hodgkin's lymphoma in nuclear medicine: diagnostic and therapeutic aspects]
J O Staak, M Dietlein, A Engert, et al.
Clinical and Experimental Immunology
|
December 2, 2008
CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential
E Kondo, L Gryschok, N Klein-Gonzalez, et al.
Annals of Hematology
|
January 25, 2002
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease
M R Weihrauch, D Re, S Bischoff, et al.
British Journal of Cancer
|
October 7, 2010
Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy
V Goede, O Coutelle, J Neuneier, et al.
Page
of 1